Errita Pharma
PT Errita Pharma is a GMP-certified Indonesian pharmaceutical manufacturer founded in 1973, producing 60 generic prescription medicines and consumer healthcare products (Citrex, Vitgo, Etabion) distributed through 50 domestic distributors.
- Company typePrivate
- Founded1973
- HeadquartersRancaekek, Indonesia
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Errita Pharma firmographics
Firmographics- Name
- Errita Pharma
- Legal name
- PT Errita Pharma
- Website
- https://errita.com
- Company type
- Private
- Founded year
- 1973
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- PT Errita Pharma is a GMP-certified Indonesian pharmaceutical manufacturer founded in 1973, producing 60 generic prescription medicines and consumer healthcare products (Citrex, Vitgo, Etabion) distributed through 50 domestic distributors.
- Ownership category
- akta.pro rank
Errita Pharma industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Generic Hospital & Institutional Products (HLAIABAL), Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where Errita Pharma is headquartered
LocationHeadquarters
- HQ city
- Rancaekek
- HQ country
- Indonesia
- HQ region
- Asia
Offices2 records
Markets served
Errita Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Generic Pharmaceutical Products: Manufacturing and sale of generic prescription medicines including branded ethical drugs, branded generics, and unbranded generic medications for acute and chronic illness treatment.
- Consumer Healthcare Products: Sale of over-the-counter products including vitamins, minerals, dietary supplements, and medical devices for pain management, general health, mobility, cognitive, gastrointestinal and children's health.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Errita Pharma product offering
Product offeringCore offering
Errita Pharma manufactures and distributes a portfolio of approximately 60 generic pharmaceutical and consumer healthcare products from its GMP-certified facility in Bandung, Indonesia. Its pharmaceutical line covers primary and specialty care treatments (antibiotics, analgesics, antihistamines, corticosteroids, cardiovascular drugs) while its consumer healthcare line includes vitamins, minerals, dietary supplements, and medical devices under sub-brands such as Citrex, Vitgo, and Etabion for children and adult health.
Product overview
PT Errita Pharma is a pharmaceutical manufacturer offering two distinct product lines: (1) Pharmaceutical products — high-quality generic prescription medicines including OTC, branded, and generic categories covering acute illness treatments (Etadryl, Etafen, Etaflusin, Etagesic, Sappmol) and specialty/ethical care products (Etabiotic, Etamox, Etafen 400, Etapril, Etarizin, Etasma, Etacurvita, Etacarvask, Etadex, Etacinolon, Bertason, Stekort, Flaxicam, Melovix, Metilon, Zochol) plus generic medications (Antasida DOEN, Domperidon, Paracetamol, Ambroxol, Amlodipine, Amoxicillin, Ampicillin, Aspira, Captopril, Cetirizine, Chloramphenicol, Cotrimoxazole, Dexamethasone, Hydrocortisone, Mefenamic Acid, Methylprednisolone, Omeprazole, Prednison, Ranitidin, Simvastatin); and (2) Consumer Healthcare products — vitamins, minerals, dietary supplements, and medical devices under the Citrex and Vitgo sub-brands targeting pain management, general health, mobility, cognitive, gastrointestinal, and children's health segments. The portfolio spans 60 products distributed through 50 distributors across Indonesia.
Differentiator
Problem solved
Functional benefit
Brands
- Citrex: Vitamin products for children including Citrex Curvita, Citrex Lysin, Citrex Smart Orange, and Citrex Smart Strawberry.
- Vitgo
- Etabion
Products and services
- Generic Pharmaceutical Products (prescription and OTC) High-quality generic pharmaceutical products covering primary care for acute illness (e.g., Etadryl, Etafen, Etaflusin, Etagesic, Sappmol) and specialty care for serious and chronic illnesses, including ethical and prescription products such as antibiotics, analgesics, antihistamines, corticosteroids, cardiovascular drugs, and unbranded generic medications (e.g., Antasida DOEN, Domperidon, Paracetamol, Ambroxol, Amlodipine, Amoxicillin, Ampicillin, Captopril, Cetirizine, Cotrimoxazole, Dexamethasone, Hydrocortisone, Mefenamic Acid, Methylprednisolone, Omeprazole, Prednison, Ranitidin, Simvastatin). Targeted at pharmacies, hospitals, clinics, and the Indonesian national health insurance (JKN/BPJS) system.
- Consumer Healthcare Products (Citrex, Vitgo, Etabion brands) Over-the-counter consumer products including vitamins, minerals, dietary supplements, and medical devices under the Citrex (children's vitamins including Citrex Curvita, Citrex Lysin, Citrex Smart Orange, Citrex Smart Strawberry), Vitgo (children's supplements including Vitgo EC, Vitgo BCO + Lysine, Vitgo Vitamin C Blackcurrant and Orange), and Etabion (general health capsules) sub-brands. Categories covered include pain management, general health, mobility, cognitive health, gastrointestinal health, and children's health. Targeted at Indonesian consumers through pharmacies, retail outlets, and promotional campaigns.
Companies that use Errita Pharma
Customer profileSegments2 records
Ideal customer profiles2 records
Errita Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Errita Pharma partnerships and signals
Strategic signalScale indicators4 records
Recent moves8 records
Expansion highlights5 records
Errita Pharma competitors and assessment
Company assessmentDirect peers
- PT Combiphar: Indonesian pharmaceutical manufacturer focused on consumer health, supplements and select prescription generics. Comparable to Errita in OTC vitamin/supplement positioning and pharmacy channel distribution in Indonesia.
- PT Kimia Farma: State-owned Indonesian pharmaceutical manufacturer and retailer producing generics, OTC and consumer health products. Closely comparable to Errita in generic manufacturing footprint, JKN participation and nationwide distribution model.
- PT Kalbe Farma: Indonesia's largest pharmaceutical company, producing generic prescription medicines, OTC products, consumer health and supplements. Directly comparable to Errita as a broad-line domestic pharma manufacturer serving pharmacies, hospitals and consumer channels in Indonesia.
- PT Dexa Medica: Indonesian pharmaceutical manufacturer focused on generic and branded medicines plus consumer health products. Comparable to Errita in product mix, GMP manufacturing scale and Indonesian distribution via third-party channels.
- PT Tempo Scan Pacific: Indonesian pharmaceutical and consumer healthcare company producing prescription generics, OTC products, vitamins and supplements under multiple brands. Closely comparable to Errita in dual pharma/consumer health portfolio and domestic distribution model.
- PT Indofarma: Indonesian state-owned pharmaceutical company manufacturing generics, consumer health and medical devices. Comparable to Errita as a domestic GMP-certified manufacturer competing for JKN/BPJS tenders and pharmacy distribution.
- PT Sanbe Farma: Indonesian generic and specialty pharmaceutical manufacturer producing a wide range of prescription and consumer healthcare products. Directly comparable to Errita in generic pharma manufacturing, hospital and retail channel reach in Indonesia.
Regional players
- Hovid Berhad: Malaysian generic pharmaceutical manufacturer producing tablets, capsules, syrups and topical formulations for domestic and export markets. Comparable to Errita in generic manufacturing capabilities, dosage-form breadth and ASEAN distribution orientation.
- Duopharma Biotech Berhad: Malaysian generic and halal-certified pharmaceutical manufacturer supplying government hospitals and consumer channels. Comparable to Errita in GMP manufacturing, Halal positioning and ASEAN pharma distribution, but primarily serves Malaysia rather than Indonesia.
Broad incumbents
- Pharmaniaga Berhad: Malaysian pharmaceutical conglomerate and Errita's parent company since 2014, manufacturing generics and supplying logistics to Malaysian government hospitals. Comparable as a regional generic manufacturer with broader government channel exposure, but at materially larger scale and broader regional footprint than Errita.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Errita Pharma compliance and trust
Trust signalCompliance5 records
Errita Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Errita Pharma leadership team
Management profileNumber of profiles
Profiles2 records
Errita Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Errita Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Errita Pharma
What does Errita Pharma do?
Errita Pharma manufactures and distributes a portfolio of approximately 60 generic pharmaceutical and consumer healthcare products from its GMP-certified facility in Bandung, Indonesia. Its pharmaceutical line covers primary and specialty care treatments (antibiotics, analgesics, antihistamines, corticosteroids, cardiovascular drugs) while its consumer healthcare line includes vitamins, minerals, dietary supplements, and medical devices under sub-brands such as Citrex, Vitgo, and Etabion for children and adult health.
Is Errita Pharma a public or private company?
Errita Pharma is a private company. It is classified as corporate owned and is currently operating.
When was Errita Pharma founded?
Errita Pharma was founded in 1973. It employs 251 to 500 people.
Where is Errita Pharma based?
Errita Pharma is headquartered in Rancaekek, Indonesia, in the Asia region.
How does Errita Pharma make money?
Two revenue lines are on record. Generic Pharmaceutical Products are the primary driver. The others are consumer Healthcare Products.
Who are Errita Pharma's main competitors?
Direct peers on record are PT Combiphar, PT Kimia Farma, PT Kalbe Farma, PT Dexa Medica, PT Tempo Scan Pacific, PT Indofarma and PT Sanbe Farma. Regional players are Hovid Berhad and Duopharma Biotech Berhad. Pharmaniaga Berhad is listed as a broad incumbent.
Does Errita Pharma have an API?
No public API is recorded for Errita Pharma.
What industry is Errita Pharma in?
Errita Pharma's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.